Article

Identification of Common Genes and Pathways Underlying Imatinib and Nilotinib Treatment in CML: a Bioinformatics Study

2023-08-31

Abstract excerpt

<title>Abstract</title> <p>Imatinib (IMA) and nilotinib are the first and second generations of BCR-ABL tyrosine kinase inhibitors which widely applied in chronic myeloid leukemia (CML) treatment. Here we aimed to provide new targets for CML treatment by transcriptome analysis. Microarray data GSE19567 was downloaded and analyzed from Gene Expression Omnibus (GEO) to identify common genes which are downregulated...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9d6af804-dfbc-5a7d-8975-05ef29e9c9a8
DOI: 10.21203/rs.3.rs-3291987/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Common Genes and Pathways Underlying Imatinib and Nilotinib Treatment in CML: a Bioinformatics StudyDOI 10.21203/rs.3.rs-3291987/v1Read

Identification of common genes and pathways underlying imatinib and nilotinib treatment in CML: a Bioinformatics StudySemantic proximity Read

Identification and validation of hub genes and molecular classifications associated with chronic myeloid leukemiaSemantic proximity Read

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemiaSemantic proximity Read

Bioinformatics analysis and identification of hub genes and immune-related molecular mechanisms in chronic myeloid leukemiaSemantic proximity Read

In silico analysis of genes and pathways related to acute myeloid leukemia presenting leukopeniaSemantic proximity Read

Identification of Novel Genes Implicated in Acute Myeloid Leukemia Progression using Bioinformatics Analysis of Microarray DataSemantic proximity Read

The Central Importance of Hub Proteins in a Disease-Gene Network Model: A New Paradigm of Chronic Myeloid Leukemia Disease StudySemantic proximity Read

Network pharmacology-based investigation and experimental validation of the mechanism of Metformin in the treatment of acute myeloid leukemiaSemantic proximity Read

Identification of acute myeloid leukemia-driven genes by multi-dimensional approachSemantic proximity Read

Comprehensive Gene Expression Analysis Reveals Factors that Influence the Progression, Occurrence and Development of AML-M4Semantic proximity Read

Significance of Gene Diagnosis in Acute Myeloid Leukemia with the Emergence of New Molecular Target Drug Treatment.Semantic proximity Read